Infographic.png (174.68 kB)
Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
media
posted on 2022-05-12, 11:11 authored by Adis Rapid Journals on behalf of:, Qing Huang, Kathleen L Deering, Qing Harshaw, Lori A LeslieThe above infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022.
